Regnum Corp.
Regnum Corp. (RGMP) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RGMP · as of Jun 9, 2026
Key Statistics
Explore Regnum Corp. Data
rgmp stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
rgmp competitorsRGMP
AMPE
BIOAF
DVLP
EVARF
GBLXStock Performance
Full HistoryAbout Regnum Corp.
Regnum Corp. is dedicated to advancing and marketing therapeutic agents designed to combat both rare and infectious diseases. Its flagship product is Leronlimab (PRO 140), a monoclonal antibody functi…
what is regnum corp. · rgmp stock overview · regnum corp. company profile · who is regnum corp. ceo · rgmp OTC · regnum corp. headquarters · regnum corp. business segments
About Stock Overview & Key Data
Regnum Corp. (RGMP) is a Healthcare company in the Biotechnology industry, listed on OTC since May 29, 2019. As of the latest trading session, RGMP stock price is $0.00, with a market capitalization of $2,295. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2022, Regnum Corp. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Regnum Corp. (RGMP) stock price is $0.00. The stock is traded on OTC under the ticker symbol RGMP. The 52-week range is $0.00 – $0.00.